These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18034586)

  • 21. Adjuvant therapy in pancreatic cancer: a critical appraisal.
    Oettle H; Neuhaus P
    Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative management of pancreatic cancer.
    Heinemann V; Boeck S
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii273-8. PubMed ID: 18790965
    [No Abstract]   [Full Text] [Related]  

  • 23. Perioperative chemotherapy with modified FOLFIRINOX for nonmetastatic pancreatic cancer: a new standard of care?
    Radi I; Samaha R; El Hajj J; Samaha H; Kourie HR
    Future Oncol; 2021 Jan; 17(3):229-233. PubMed ID: 33305614
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of adjuvant therapy in the management of pancreatic cancer.
    Laheru D; Yeo CJ
    Adv Surg; 2005; 39():223-44. PubMed ID: 16250554
    [No Abstract]   [Full Text] [Related]  

  • 25. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Status of neoadjuvant therapy for resectable pancreatic cancer.
    Hoffman JP
    Surg Oncol Clin N Am; 2010 Apr; 19(2):411-8. PubMed ID: 20159522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant Treatment in Potentially Curable Pancreatic Cancer: Need to Include Tumor Location in the Equation?
    Mukhija D; Sohal DPS; Khorana AA
    Pancreas; 2018 Sep; 47(8):e50-e52. PubMed ID: 30113430
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of pancreatic carcinoma. Is there a role for radiotherapy and chemotherapy?
    Wils JA; Bleiberg H
    Acta Gastroenterol Belg; 1987; 50(1):114-20. PubMed ID: 2447729
    [No Abstract]   [Full Text] [Related]  

  • 29. Rationale and appropriate use of chemotherapy and radiotherapy for pancreatic ductal adenocarcinoma.
    Marsh Rde W; George T
    Curr Gastroenterol Rep; 2006 Apr; 8(2):111-20. PubMed ID: 16533473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
    Meszoely IM; Wang H; Hoffman JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant therapy for pancreas cancer: advances and controversies.
    Mulcahy MF
    Semin Oncol; 2007 Aug; 34(4):321-6. PubMed ID: 17674960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adjuvant chemotherapy for colorectal cancer: Its efficacy and problems].
    Imanishi T; Kamigaki T; Kuroda Y
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():315-20. PubMed ID: 14574902
    [No Abstract]   [Full Text] [Related]  

  • 33. Advanced pancreatic cancer--5 years on.
    Rao S; Cunningham D
    Ann Oncol; 2002 Aug; 13(8):1165-8. PubMed ID: 12181237
    [No Abstract]   [Full Text] [Related]  

  • 34. Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma.
    Du L; DeFoe M; Ruzinova MB; Olsen JR; Wang-Gillam A
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):717-26. PubMed ID: 26226906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in the treatment of gastrointestinal cancer.
    Massidda B; Rougier P
    Ann Oncol; 2003; 14 Suppl 2():ii1-2. PubMed ID: 12810449
    [No Abstract]   [Full Text] [Related]  

  • 36. Second-line therapy in pancreatic cancer.
    Skoura E; Syrigos KN; Saif MW
    JOP; 2013 Mar; 14(2):133-4. PubMed ID: 23474554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research in pancreatic cancer: an update after ASCO 2012.
    Saif MW
    JOP; 2012 Jul; 13(4):330-1. PubMed ID: 22797382
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody-drug conjugate may inhibit pancreatic cancer.
    Cancer Discov; 2013 Dec; 3(12):OF1. PubMed ID: 24327698
    [No Abstract]   [Full Text] [Related]  

  • 39. ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients.
    Olecki EJ; Gusani NJ
    Ann Surg Oncol; 2021 Jun; 28(6):3123. PubMed ID: 33616769
    [No Abstract]   [Full Text] [Related]  

  • 40. Pancreatic cancer: a new target for adjuvant therapy and chemotherapy.
    Muggia FM; Megibow A; Douglass HO
    Prog Clin Biol Res; 1985; 201():295-300. PubMed ID: 4095114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.